Clinical Trial Update: Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating allogeneic hepatocyte transplantation into periduodenal lymph nodes for end-stage liver disease, sponsored by LyGenesis, In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Drugs mentioned

• Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes

Snippet

Sponsor: LyGenesis, Inc. | Conditions: End Stage Liver Disease | Phase 2 | Status: RECRUITING